Posts By Alex
-
543Wire StoriesImmunAbs Inc. Announces US FDA Approval for a Phase 1 Clinical Trial
SEOUL, South Korea–(BUSINESS WIRE)–ImmunAbs Inc. (www.immunabs.com) announced that it has received US FDA approval for a Phase 1 clinical trial and that...
-
550Wire StoriesLG Chem Enters Final Stage of Clinical Development for New Gout Drug
SEOUL, South Korea & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#Gout–LG Chem recently announced that the Company has submitted an IND application to the US FDA...
-
478Wire StoriesThailand Connected Trucks Telematics Market Analysis/Opportunities Report 2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Thailand Connected Trucks Telematics Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. This research service analyzes the impact of...
-
608Wire StoriesPropanc Biopharma Establishes Joint Research Collaboration Agreement with the Universities of Ja�n and Granada
Research Evaluates Effects of Against the Tumor Microenvironment MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (�Propanc� or the �Company�), a biopharmaceutical company...
-
474Wire StoriesFirstWave Cloud�s Revolutionary Open Security Management Platform (OSMP) Delivers On �Urgent� Need For SMB Cyber Protection
SYDNEY, Australia–(BUSINESS WIRE)–#asx–Comprehensive cyber protection for SMBs has emerged as the next great revenue driver for IT service providers, with 60% of...
-
513Wire StoriesRising Cost of Living Driving 1 in 2 Consumers to Cut Back on Spending, According to LoopMe Survey
Of nearly 18,000 consumers surveyed in U.S., U.K., and Australia, 67% do not want to work from the office, and 18% would...
-
564Wire StoriesOSI Systems� Chief Executive Officer Appointed to U.S. � India CEO Forum
HAWTHORNE, Calif.–(BUSINESS WIRE)–OSI Systems, Inc. (NASDAQ: OSIS) announces that its Chairman and Chief Executive Officer, Deepak Chopra, has been appointed by the...
-
518Wire StoriesShape Memory Medical Celebrates Treatment of 1,500th Patient
SANTA CLARA, Calif.–(BUSINESS WIRE)–#ShapeMemoryPolymer–Shape Memory Medical Inc., developer of shape memory polymer devices for peripheral and neurovascular markets, announced today that its...
-
489Wire StoriesOliX Pharmaceuticals Receives IND Approval from FDA to Develop RNAi Therapeutic OLX10212 for Age-related Macular Degeneration
SUWON, South Korea–(BUSINESS WIRE)–#AgeRelatedMacularDegeneration—OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the U.S. Food and Drug...
-
536Wire StoriesPharmaEssentia Appoints Dr. Lih-Ling Lin as Chief Scientific Officer
Dr. Lin, formerly of Sanofi, to lead expansion and acceleration of global R&D efforts BURLINGTON, Mass.–(BUSINESS WIRE)–PharmaEssentia Corporation, (TPEx:6446), a global biopharmaceutical...
